logo
AAT Bioquest

XFD660 NHS Ester [equivalent to Alexa Fluor® 660 NHS Ester]

Product key features

  • Ex/Em: 663/691 nm
  • Extinction coefficient: 132,000 cm-1M-1
  • Reactive Group: NHS ester
  • Easy Conjugation: Efficiently labels primary amines on proteins, ligands, and amine-modified oligonucleotides
  • Bright & Stable: Delivers intense fluorescence with resilience to photobleaching and pH variations from 4 to 10
  • Hydrophilic: Minimizes aggregation, enhancing signal clarity for advanced imaging and live-cell studies

Product description

XFD660, synthesized by AAT Bioquest, shares the exact same chemical structure with Alexa Fluor® 660 (a ThermoFisher trademark). This far-red dye is optimized for excitation by the 633 or 647 nm laser lines, making it well-suited for applications in imaging and flow cytometry where bright and photostable signal generation is critical. XFD660 is water-soluble and demonstrates pH stability within a range from 4 to 10. The NHS ester derivative of XFD660 is predominantly employed for conjugation to proteins or antibodies. This functionality allows the NHS ester to covalently attach to the primary amines present in proteins, amine-modified oligonucleotides, and other amine-bearing molecules. Conjugates utilizing XFD660 are noted for their enhanced fluorescence intensity and increased photostability relative to conjugates using other fluorophores with similar spectral characteristics.

Example protocol

PREPARATION OF STOCK SOLUTIONS

Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles

Protein Stock Solution (Solution A)
  1. Prepare a 1 mL protein labeling stock solution by mixing 100 µL of reaction buffer (such as 1 M sodium carbonate solution or 1 M phosphate buffer, pH ~9.0) with 900 µL of the target protein solution (e.g., an antibody with a protein concentration of at least 2 mg/mL, if possible).

    Note: The pH of the protein solution (Solution A) should be 8.5 ± 0.5. If the pH of the protein solution is lower than 8.0, adjust it to within the 8.0-9.0 range using either 1 M  sodium bicarbonate solution or 1 M phosphate buffer at pH 9.0.

    Note: The protein should be dissolved in 1X phosphate-buffered saline (PBS), pH 7.2-7.4. If the protein is dissolved in Tris or glycine buffer, dialyze it against 1X PBS, pH 7.2-7.4, to remove any free amines or ammonium salts (such as ammonium sulfate and ammonium acetate) commonly used in protein precipitation.

    Note: Antibodies that are impure or stabilized with bovine serum albumin (BSA) or gelatin may not label effectively. Additionally, sodium azide or thimerosal can interfere with the conjugation reaction. To achieve optimal labeling results, these preservatives should be removed through dialysis or spin column techniques.

    Note: For optimal labeling efficiency, it is recommended to maintain a final protein concentration between 2-10 mg/mL. Protein concentrations below 2 mg/mL can significantly reduce conjugation efficiency.

XFD660 NHS Ester Stock Solution (Solution B)
  1. To prepare a 10 mM stock solution of XFD660 NHS ester, add anhydrous DMSO directly to the vial of XFD660 NHS ester. Mix well by pipetting or vortexing.

    Note: Prepare the dye stock solution (Solution B) before starting the conjugation, and use it promptly. Extended storage of the dye stock solution may reduce the dye activity. Solution B can be stored in the freezer for up to two weeks, provided it is protected from light and moisture. Avoid freeze-thaw cycles.

SAMPLE EXPERIMENTAL PROTOCOL

This protocol is designed for labeling Goat anti-mouse IgG with XFD660 NHS ester. Additional optimization may be required to adapt the protocol to your specific proteins.

Note: Each protein requires a distinct dye/protein ratio, which varies depending on the characteristics of the dye. Over-labeling a protein can negatively impact its binding affinity, whereas using a low dye-to-protein ratio in protein conjugates can result in reduced sensitivity.

Run Conjugation Reaction
  1. Use a 10:1 molar ratio of Solution B (dye) to Solution A (protein) as the starting point: Add 5 µL of the dye stock solution (Solution B, assuming the dye stock solution is 10 mM) to the vial containing the protein solution (95 µL of Solution A) with effective shaking. The concentration of the protein is ~0.05 mM, assuming the protein concentration is 10 mg/mL and the molecular weight of the protein is ~200KD.

    Note: We recommend using a 10:1 molar ratio of Solution B (dye)/Solution A (protein). If it is too low or too high, determine the optimal dye/protein ratio at 5:1, 15:1, and 20:1, respectively.

  2. Continue to rotate or shake the reaction mixture at room temperature for 30-60 minutes.

Purify the Conjugate

The following protocol demonstrates the purification of a dye-protein conjugate using a Sephadex G-25 column.

  1. Prepare the Sephadex G-25 column according to the manufacturer's instructions.

  2. Carefully load the reaction mixture (from the "Run Conjugation Reaction" step) to the top of the Sephadex G-25 column.

  3. Add PBS (pH 7.2-7.4) as soon as the sample runs just below the top resin surface.

  4. Add more PBS (pH 7.2-7.4) to the desired sample to complete the column purification. Combine the fractions that contain the desired dye-protein conjugate.

    Note: For immediate use, the dye-protein conjugate must be diluted with staining buffer, and aliquoted for multiple uses.

    Note: For longer-term storage, the dye-protein conjugate solution needs to be concentrated or freeze-dried.

Characterize the Desired Dye-Protein Conjugate

The Degree of Substitution (DOS) is a critical factor in characterizing dye-labeled proteins. Proteins with a lower DOS generally exhibit weaker fluorescence, while those with a higher DOS (e.g., DOS > 6) may also show reduced fluorescence. The optimal DOS for most antibodies typically ranges between 2 and 10, depending on the specific properties of both the dye and the protein. For effective labeling, it is recommended to achieve a DOS of 6-8 moles of XFD660 NHS ester per mole of antibody. The following steps outline the process for determining the DOS of XFD660 NHS ester-labeled proteins.

Measure Absorption

For accurate measurement of the absorption spectrum of a dye-protein conjugate, maintain the sample concentration between 1-10 µM, adjusting as needed based on the dye's extinction coefficient.

Read OD (absorbance) at 280 nm and Dye Maximum Absorption (ƛmax = 663 nm for XFD660 NHS Ester)

For most spectrophotometers, the sample (from the column fractions) needs to be diluted with de-ionized water so that the O.D. values are in the range of 0.1 to 0.9. The O.D. (absorbance) at 280 nm is the maximum absorption of protein, while 663 nm is the maximum absorption of XFD660 NHS ester. To obtain accurate DOS, ensure the conjugate is free of the non-conjugated dye.

Calculate DOS

You can calculate DOS using our tool by following this link:

https://www.aatbio.com/tools/degree-of-labeling-calculator

Spectrum

Product family

NameExcitation (nm)Emission (nm)Extinction coefficient (cm -1 M -1)Correction Factor (260 nm)Correction Factor (280 nm)
XFD488 NHS Ester *Same Structure to Alexa Fluor™ 488 NHS Ester*499520710000.300.11
XFD350 NHS Ester *Same Structure to Alexa Fluor™ 350 NHS Ester*343441190000.250.19
XFD532 NHS Ester *Same Structure to Alexa Fluor™ 532 NHS Ester*534553810000.240.09
XFD594 NHS Ester *Same Structure to Alexa Fluor™ 594 NHS Ester*590618900000.430.56
XFD555 NHS Ester *Same Structure to Alexa Fluor™ 555 NHS Ester*5535681500000.080.08
XFD647 NHS Ester *Same Structure to Alexa Fluor™ 647 NHS Ester*6506712390000.000.03
XFD680 NHS Ester *Same Structure to Alexa Fluor™ 680 NHS Ester*6817041840000.000.05
XFD700 NHS Ester *Same Structure to Alexa Fluor™ 700 NHS Ester*6967191920000.000.07
XFD750 NHS Ester *Same Structure to Alexa Fluor™ 750 NHS Ester*7527762400000.000.04
XFD546 NHS Ester *Same Structure to Alexa Fluor™ 546 NHS Ester*5615721120000.210.12
XFD568 NHS Ester *Same Structure to Alexa Fluor™ 568 NHS Ester*579603913000.450.46
XFD514 NHS Ester *Same Structure to Alexa Fluor™ 514 NHS Ester*518543800000.310.18
XFD405 NHS Ester [equivalent to Alexa Fluor™ 405 NHS Ester]40142135,0000.230.70
XFD430 NHS ester43254015,000-0.28
XFD610 NHS Ester611629144,0000.430.44
XFD633 NHS Ester632650159,000-0.55
QXY21 NHS ester [equivalent to QSY-21 NHS ester]--890001-0.32
Cy5DIGE NHS ester65167025000010.020.03
Cy2DIGE NHS ester4925081500000.080.15
Cy3DIGE NHS ester55556915000010.070.073
QXY7 NHS ester [equivalent to QSY-7 NHS ester]--900001-0.22
Cy3B NHS ester56057112000010.0480.069
CypHer5E NHS Ester643660---
CypHer7E NHS Ester748769---
Show More (15)

References

View all 50 references: Citation Explorer
Enhanced fluorescence blinking of AF647 fluorophores in Mowiol via violet and UV light induced recovery for superior localization microscopy.
Authors: Bharadwaj, Anupam and Kumar, Amalesh and Mitra, Rumela and Jaganathan, Bithiah Grace and Boruah, Bosanta Ranjan
Journal: Methods and applications in fluorescence (2024)
Three species multiplexing of fluorescent dyes and gold nanoclusters recovered with fluorescence lifetime correlation spectroscopy.
Authors: Kayyil Veedu, Malavika and Hajda, Agata and Olesiak-Bańska, Joanna and Wenger, Jérôme
Journal: Biochimica et biophysica acta. General subjects (2024): 130611
Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer.
Authors: Iorhemba, Michael Aondona and Álvarez-Conde, Javier and Díaz-García, Diana and Méndez-Arriaga, José Manuel and García-Almodóvar, Victoria and Ovejero-Paredes, Karina and Idris, Sulaiman Ola and Shallangwa, Gideon Adamu and Abdulkadir, Ibrahim and Prashar, Sanjiv and Filice, Marco and Gómez-Ruiz, Santiago
Journal: Biomedical materials (Bristol, England) (2024)
Amphiphilic Poly(2-oxazoline)s with Glycine-Containing Hydrophobic Blocks Tailored for Panobinostat- and Imatinib-Loaded Micelles.
Authors: Göppert, Natalie E and Quader, Sabina and Van Guyse, Joachim F R and Weber, Christine and Kataoka, Kazunori and Schubert, Ulrich S
Journal: Biomacromolecules (2023): 5915-5925
USE OF RECOMBINANT S1 PROTEIN WITH hFc FOR ANALYSIS OF SARS-COV-2 ADSORPTION AND EVALUATION OF DRUGS THAT INHIBIT ENTRY INTO VERO E6 CELLS.
Authors: Couto, Jéssica Carla Martins and Vidal, Taís and Decker, Eduardo Reichert and Santurio, Janio M and de Mello, Carlos Fernando and Pillat, Micheli Mainardi
Journal: Immunology letters (2023)
Page updated on December 17, 2024

Ordering information

Price
Unit size
Catalog Number1834
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Physical properties

Molecular weight

1079.39

Solvent

DMSO

Spectral properties

Correction Factor (260 nm)

0.00

Correction Factor (280 nm)

0.10

Extinction coefficient (cm -1 M -1)

132000

Excitation (nm)

663

Emission (nm)

691

Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22

Storage

Freeze (< -15 °C); Minimize light exposure
UNSPSC12171501
Product Image
Product Image
Gallery Image 1

Alternative formats